e-Therapeutics (LSE:ETX) YoY Rev. per Sh. Growth : -100.00% (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. e-Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Jul. 2023 was -100.00%.

e-Therapeutics's Revenue per Share for the six months ended in Jul. 2023 was £0.00.

e-Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for e-Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics YoY Rev. per Sh. Growth Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-50.00

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-	-100.00	-	-	-100.00

e-Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

e-Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Jan. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Jan. 2023 )
=	(Revenue per Share (A: Jan. 2023 )	-	Revenue per Share (A: Jan. 2022 ))	/	\| Revenue per Share (A: Jan. 2022 ) \|
=	(0.001	-	0.001)	/	\| 0.001 \|
=	0.00 %

e-Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Jul. 2023 is calculated as:

	YoY Rev. per Sh. Growth (Q: Jul. 2023 )
=	(Revenue per Share (Q: Jul. 2023 )	-	Revenue per Share (Q: Jul. 2022 ))	/	\| Revenue per Share (Q: Jul. 2022 )) \|
=	(0	-	0.001)	/	\| 0.001 \|
=	-100.00 %

e-Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

ETXPF:USA 3AQ:Germany

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021